this prospective , double-blind , multicenter study compared enalapril plus hydrochlorothiazide with standard triple therapy ( stt ; hydrochlorothiazide , timolol , and hydralazine ) with regard to safety , tolerability , antihypertensive efficacy , and effect on renal function in 75 patients with documented renovascular hypertension .
C0717738
enalapril
C0020261
hydrochlorothiazide